Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions
CA 2383268 A1 · Owner: Satoh, Yoshitaka · Inventors: Satoh, Yoshitaka; Bennett, Brydon L.; O'Leary, Eoin C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds having activity as selective inhibitors of JNK are disclosed. The compounds of this invention are pyrazoloanthrone and derivatives thereof having structure (I) wherein R1 and R2 are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to JNK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.